Related Experiment Video
Updated: Jun 5, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Merrill Jon Egorin, MD, 1948-2010.
M J Ratain1, J M Collins, J H Doroshow
1Department of Medicine, University of Chicago, Chicago, Illinois, USA. mratain@medicine.bsd.uchicago.edu
Merrill Egorin pioneered research into pharmacokinetic variability and its impact on anticancer drug effectiveness. His work advanced the understanding of how individual differences affect cancer treatment outcomes.
Area of Science:
- Pharmacology
- Oncology
- Clinical Pharmacy
Background:
- Merrill Egorin's early education and formative years were spent in Baltimore, Maryland.
- He established himself as a key figure in the field of cancer pharmacotherapy.
Discussion:
- Egorin's research focused on the critical interplay between pharmacokinetic variability and pharmacodynamics.
- This investigation aimed to optimize the efficacy and safety of anticancer agents.
Key Insights:
- He was instrumental in elucidating how individual patient factors influence drug response in cancer treatment.
- His contributions provided a foundation for personalized cancer medicine.
Outlook:
- Egorin's legacy includes not only scientific advancements but also his dedication to mentorship and compassionate patient care.
- His work continues to influence the development of targeted cancer therapies.
Related Concept Videos
Methods of Documentation VII: EMR
Erikson's Theory on Socioemotional Development during Adulthood
Intimacy Versus Isolation in Early Adulthood
Individuals in early adulthood, from the 20s...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Role of ER in the Secretory Pathway
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Pharmacodynamics in Geriatric Patients: Effects of Age

